This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

PPD Named Best Contract Research Organization And Honored For Best Technological Development In Clinical Trials By Scrip

Stocks in this article: PPDI

Pharmaceutical Product Development, Inc. (Nasdaq: PPDI) today announced it has been named the best contract research organization by Scrip Intelligence, which also has honored PPD for deploying the best technological development in clinical trials.

Scrip presented both awards to PPD at the seventh annual Scrip Awards ceremony on November 3 in London. PPD was recognized for its expertise and innovation in helping clients develop life-changing medical treatments. The judging panel called PPD “a great organization – open for new approaches, even more for driving new technologies.”

“At PPD, we share our clients’ passion for delivering new therapies to help people live healthier lives,” said Raymond Hill, chief executive officer of PPD. “These awards pay testament to the hard work, dedication and inspiration that our employees deliver every day to provide exceptional client service. We are committed to delivering consistent high quality, innovative ideas and forward-focused technologies that help our clients achieve their vision.”

Launched in 1985 as a one-person consulting firm, today PPD is one of the world’s leading contract research organizations. PPD has worked with 49 of the top 50 pharmaceutical companies to speed the delivery of life-changing therapies to people in need.

Scrip also recognized PPD’s innovative technology solution, created in collaboration with Microsoft Corp., that improves the efficiency of managing Risk Evaluation and Mitigation Strategy (REMS) programs mandated by the U.S. Food and Drug Administration. Designed to improve patient safety, REMS programs help ensure the safe distribution and administration of certain marketed drugs.

The PPD REMS solution is a first-of-its-kind technology platform that integrates, manages and tracks all REMS resources, data and information. It is based on the Microsoft Amalga Unified Intelligence System, a data aggregation platform that gives healthcare professionals access to the information they need when they need it, and Microsoft HealthVault, a personal health application platform that lets consumers gather, store and share health information online.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs